Insight from mitochondrial functions and proteomics to understand cardiometabolic disorders in survivors of acute lymphoblastic leukemia

• Published in: Metabolism, clinical and experimental clinical and experimental, 2018-08, Vol.85, p.151-160
• Main Authors: Leahy, Jade, Spahis, Schohraya, Bonneil, Eric, Garofalo, Carole, Grimard, Guy, Morel, Sophia, Laverdière, Caroline, Krajinovic, Maja, Drouin, Simon, Delvin, Edgard, Sinnett, Daniel, Marcil, Valérie, Levy, Emile
• Format: Article
• Language: English
• Subjects: Acute lymphoblastic leukemia; Adult; Cancer; Cancer Survivors; Cardiovascular Diseases - metabolism; Female; Humans; Leukocytes, Mononuclear - metabolism; Male; Metabolic Diseases - metabolism; Metabolic syndrome; Metabolic Syndrome - metabolism; Mitochondria; Mitochondria - metabolism; Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism; Proteomic; Proteomics; Survivors; Young Adult
• ISSN: 0026-0495; 1532-8600
• DOI: 10.1016/j.metabol.2018.03.011

Childhood acute lymphoblastic leukemia (cALL) is the most prevalent form of cancer in children. Due to advances in treatment and therapy, young cALL subjects now achieve a 90% survival rate. However, this tremendous advance does not come without consequence since ~2/3 of cALL survivors are affected by long-term and late, severe complications. Although the metabolic syndrome is a very serious sequel of cALL, the mechanisms remain undefined. It is also surprising to note that the mitochondrion, a central organelle in metabolic functions and the main cellular energy generator, have not yet been explored. To determine whether cALL survivors exhibit impairments in their mitochondrial functions and proteomic profiling in relationship with metabolic disorders in cALL survivors compared to healthy controls. Anthropometric measures, metabolic characteristics and lipid profiles were assessed, mitochondria isolated from peripheral blood mononuclear cells, and proteomic analyzed. Our data demonstrated that metabolically. Unhealthy survivors exhibited several metabolic syndrome components (e.g. overweight, insulin resistance, dyslipidemia, inflammation) whereas Healthy cALL survivors resemble the Controls. In line with these abnormalities, functional experiments in these subjects revealed a significant decrease in the protein expression of mitochondrial antioxidant superoxide dismutase, PGC1-α transcription factor (a key modulator of mitochondrion biogenesis), and an increase in pro-apoptotic cytochrome c. Proteomic analysis of mitochondria by mass spectrometry revealed changes in the regulation of proteins related to inflammation, apoptosis, energy production, redox and antioxidant activity, fatty acid β-oxidation, protein transport and metabolism, and signalling pathways between groups. Through the use of proteomic analysis, our work demonstrated a number of significant alterations in protein expression in mitochondria of cALL survivors, especially the metabolically Unhealthy survivor group. Further investigation of these proteins may help delineate the mechanisms by which mitochondrial dysfunctions exert cardiometabolic derangements in cALL survivors. [Display omitted] •Significant metabolic disturbance in cALL.•Mitochondria abnormalities in acute lymphoblastic leukemia.•Therapeutic strategies targeting mitochondria.